Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Qin CX"'
Autor:
Velagic A; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.; Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia., Li JC; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.; Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia., Qin CX; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.; Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia., Li M; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.; Biomedicine Discovery Institute, Department of Pharmacology, Monash University, Melbourne, VIC, Australia., Deo M; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.; Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia., Marshall SA; The Ritchie Centre, Department of Obstetrics and Gynaecology, School of Clinical Sciences, Monash University, VIC, Australia., Anderson D; Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia., Woodman OL; Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia., Horowitz JD; Basil Hetzel Institute, Queen Elizabeth Hospital, University of Adelaide, SA, Australia., Kemp-Harper BK; Biomedicine Discovery Institute, Department of Pharmacology, Monash University, Melbourne, VIC, Australia., Ritchie RH; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.; Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia.; Biomedicine Discovery Institute, Department of Pharmacology, Monash University, Melbourne, VIC, Australia.
Publikováno v:
British journal of pharmacology [Br J Pharmacol] 2022 Aug; Vol. 179 (16), pp. 4117-4135. Date of Electronic Publication: 2022 Apr 26.
Autor:
Qin CX; Heart Failure Pharmacology, Baker Heart & Diabetes Institute, Melbourne, Australia.; Department of Pharmacology and Therapeutics, University of Melbourne, Melbourne, Australia.; Department of Medicine (Central Clinical School), Monash University, Melbourne, Australia., Anthonisz J; Heart Failure Pharmacology, Baker Heart & Diabetes Institute, Melbourne, Australia.; Department of Medicine (Central Clinical School), Monash University, Melbourne, Australia., Leo CH; School of Biosciences, University of Melbourne, Parkville, Australia.; Science and Maths Cluster, Singapore University of Technology & Design, Singapore Singapore., Kahlberg N; School of Biosciences, University of Melbourne, Parkville, Australia., Velagic A; Heart Failure Pharmacology, Baker Heart & Diabetes Institute, Melbourne, Australia.; Department of Medicine (Central Clinical School), Monash University, Melbourne, Australia., Li M; Heart Failure Pharmacology, Baker Heart & Diabetes Institute, Melbourne, Australia., Jap E; Heart Failure Pharmacology, Baker Heart & Diabetes Institute, Melbourne, Australia., Woodman OL; Heart Failure Pharmacology, Baker Heart & Diabetes Institute, Melbourne, Australia., Parry LJ; School of Biosciences, University of Melbourne, Parkville, Australia., Horowitz JD; Cardiology Unit, The Queen Elizabeth Hospital, Basil Hetzel Institute, The University of Adelaide, Woodville SA, Australia., Kemp-Harper BK; Department of Pharmacology, Biomedicine Discovery Institute, Monash University, Clayton, Australia., Ritchie RH; Heart Failure Pharmacology, Baker Heart & Diabetes Institute, Melbourne, Australia.; Department of Pharmacology and Therapeutics, University of Melbourne, Melbourne, Australia.; Department of Medicine (Central Clinical School), Monash University, Melbourne, Australia.
Publikováno v:
Antioxidants & redox signaling [Antioxid Redox Signal] 2020 Jan 01; Vol. 32 (1), pp. 60-77.